HERON THERAPEUTICS, INC. /DE/ Paid-in-Kind Interest
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Paid-in-Kind Interest of $2.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ paid-in-kind interest for the quarter ending 2026-06-30 was $600.00K.
- HERON THERAPEUTICS, INC. /DE/ paid-in-kind interest for the quarter ending 2026-03-31 was $1.60M.
- HERON THERAPEUTICS, INC. /DE/ paid-in-kind interest for the quarter ending 2012-09-30 was $51.00K.
- HERON THERAPEUTICS, INC. /DE/ paid-in-kind interest for the quarter ending 2012-06-30 was $24.00K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month |
|---|---|---|---|
| 2026-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.20M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.60M 10-Q · filed 2026-05-11 | ||
| 2012-09-30 | $51.00K 10-Q · filed 2012-11-05 | $75.00K derived: sum of 2 quarters · filed 2012-11-05 | $98.00K 10-Q · filed 2012-11-05 |
| 2012-06-30 | $24.00K 10-Q · filed 2012-08-09 | $48.00K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |